Wednesday 8 February 2012

Excellence in Hemoglobinopathies research awards program

The National Institutes of Health, more commonly called the NIH is an agency of the Federal Government to operate in United States Department of Health and Human Services properly loaded to support studies of biomedical and research related to the health of the country.

Programs and NIH grants are equipped specifically to assist in the implementation of its overall mission of Agency to "search the knowledge base on the nature and behavior of living systems and the application of this information to improve health, extend life and scale back the burden of disease and disability."

In line with this mission, the National Institutes of Health created in collaboration with the National Heart, Lung and Blood Institute (NHLBI) to establish Excellence in research awards program Hemoglobinopathies that the two organizations have agreed to financially support the creation of studies that could probably improve basic research and translational multidisciplinary high impact, in Hemoglobinopathies.

Initially, NIH, and NHLBI will conclude a cooperation agreement of five years with the strongest applicant who submitted a proposal which would be potentially therapeutic molecules, biomarkers and imaging modalities in the field of Hemoglobinopathies.

It is the hope of the NHLBI which proposals will lead the way to more interdisciplinary approaches of translational research on Hemoglobinopathies, which implies a higher high impact research become finally chance to applied clinical research studies.

The final aim of studies which will be proposed in this project are focused on the discovery of small molecules, Biologics and biomarkers that can all be used in the process of diagnosis, treatment and management of Thalassemia or sickle cell disease.

The NHLBI is to administer the grant of 7 to 10 awards with an overall budget of $67.95, with a total cost of 14 million for the year 2013 only.

Facilities and institutions which will supposedly eligible to apply under the Excellence in Hemoglobinopathies fellowship program are as follows:

(a) higher education Public/State controlled Institutions of higher education and private higher education Institutions

(b) apart from the institutions of higher education non-profit organizations

(c) non-profit, as small businesses and other organizations other than small businesses

(d) State Governments, county governments, city or township Governments and administrations of Special District

(e) Independent School Districts, housing authorities/Indian housing authorities, Native American tribal organizations (other than tribal governments recognized by the Federal Government), based on the faith or community organizations and regional organizations.

Michael Saunders is a publisher of TopGovernmentGrants.com. He maintains Web sites offering resources on subsidies for small businesses and home renovation grants.


View the original article here

No comments:

Post a Comment